CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2022; 43(01): 097-102
DOI: 10.1055/s-0042-1742661
Brief Communication

Prevalence and Determinants of Human Papilloma Virus Infection and Cervical Intraepithelial Neoplasia (CIN) among Women Living with HIV/AIDS in Mumbai, India

Vandita Pahwa
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Kavita V. Anand
1   Department of Preventive Oncology, Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations
Source of Funding None.

Abstract

Human immunodeficiency virus (HIV) infection among women predisposes them to human papillomavirus (HPV) infection, the causative agent for cervical cancer. The study retrospectively analyzed the data of 291 women living with HIV AIDS (Acquired immunodeficiency syndrome) to assess the prevalence and determinants of the HPV infection and cervical intraepithelial neoplasia (CIN). The study found a high prevalence of cervical HPV infection (34.4%), CIN I (6.2%), and CIN II+ (8.6%). Participants with HPV DNA positivity are significantly more likely to be aged younger than 35 years (odds ratio [OR] = 1.64, 95% confidence interval [CI] = 1.01–2.69), housewives (OR = 2.29, 95% CI = 1.31–3.99), married at <20 years of age (OR = 2.02, 95% CI = 1.13–3.58), and have been pregnant more than two times (OR = 1.76, 95% CI = 1.08–2.87). Participants with CIN II+ are significantly more likely to be not married (OR = 3.363, 95% CI = 1.302–8.686). Considering the high prevalence of HPV and CIN observed among HIV women, it is worthwhile to integrate cervical cancer awareness programs and screening with routine follow-up of HIV patients at antiretroviral therapy clinic. This susceptible population needs attention to reduce the burden of cervical cancer in the country.

Authors' Contribution

S.A.P. had the initial idea and was responsible for the conduct of the study, and participated in its conception and design, monitoring, supervision, acquisition, and interpretation of the data and the provision of clinical services in the study. V.P. was responsible for monitoring, supervision, acquisition, and interpretation of the data. G.A.M. was responsible for the study design, conduct, monitoring and supervision of the study, acquisition, analysis, and interpretation of the data. K.V.A. participated in the conduct and monitoring of the study, acquisition, and interpretation of data. All authors were involved in drafting the manuscript and have read and approved the text as submitted to the journal.


S.A.P., as corresponding author, confirms that she had access to all data and had final responsibility for the decision to submit for publication.




Publication History

Article published online:
17 February 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 World Health Organization. Human papillomavirus (HPV) and cervical cancer fact sheet. 2020
  • 2 de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol 2018; 47: 2-13
  • 3 International Agency for Research on Cancer. GLOBOCAN 2020: New Global Cancer Data. 2021
  • 4 International Agency for Research on Cancer. GLOBOCAN India 2020. 2021
  • 5 van Hamont D, Bekkers RL, Massuger LF, Melchers WJ. Detection, management, and follow-up of pre-malignant cervical lesions and the role for human papillomavirus. Rev Med Virol 2008; 18 (02) 117-132
  • 6 National AIDS Control Organization & ICMR-National Institute of Medical Statistics. India HIV Estimates 2019: Report. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India; 2020 Available at: UNAIDS_INDIA HIV ESTIMATES-2.indd (naco.gov.in). Accessed September 22, 2021
  • 7 Whitham HK, Hawes SE, Chu H. et al. A comparison of the natural history of HPV infection and cervical abnormalities among HIV-positive and HIV-negative women in Senegal, Africa. Cancer Epidemiol Biomarkers Prev 2017; 26 (06) 886-894
  • 8 World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021
  • 9 Taku O, Businge CB, Mdaka ML. et al. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa. Int J Infect Dis 2020; 95: 176-182
  • 10 Sarkar K, Pal R, Bal B. et al. Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis 2011; 11: 72
  • 11 Averbach SH, Gravitt PE, Nowak RG. et al. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS 2010; 24 (07) 1035-1042
  • 12 Chakravarty J, Chourasia A, Thakur M, Singh AK, Sundar S, Agrawal NR. Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India. Indian J Med Res 2016; 143 (01) 79-86
  • 13 Nyasenu YT, Gbeasor-Komlanvi FA, Ehlan A. et al. Prevalence and distribution of human papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo. PLoS One 2019; 14 (02) e0212516
  • 14 Teixeira MF, Sabidó M, Leturiondo AL, de Oliveira Ferreira C, Torres KL, Benzaken AS. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas. Virol J 2018; 15 (01) 36
  • 15 Sahasrabuddhe VV, Bhosale RA, Joshi SN. et al. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 2010; 5 (01) e8634
  • 16 Bogale AL, Belay NB, Medhin G, Ali JH. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis. Virol J 2020; 17 (01) 179
  • 17 Patel P, Rose CE, Collins PY. et al; NIH HIV/NCD Project Disease Condition Technical Operating Group. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS 2018; 32 (1, suppl 1): S5-S20
  • 18 Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara Regional State, Ethiopia: a hospital-based cross-sectional study. Int J Health Sci (Qassim) 2019; 13 (03) 4-9
  • 19 Atashili J, Miller WC, Smith JS. et al. Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC Res Notes 2012; 5: 590
  • 20 Daniel GO, Musa J, Akindigh TM. et al. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria. Int J Gynaecol Obstet 2020; 151 (02) 253-259